Kewaunee Scientific Corporation

NasdaqGM:KEQU Stock Report

Market Cap: US$104.7m

Kewaunee Scientific Past Earnings Performance

Past criteria checks 3/6

Kewaunee Scientific has been growing earnings at an average annual rate of 19.3%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 9.5% per year. Kewaunee Scientific's return on equity is 19.8%, and it has net margins of 4.3%.

Key information

19.3%

Earnings growth rate

18.8%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate9.5%
Return on equity19.8%
Net Margin4.3%
Last Earnings Update31 Jan 2024

Recent past performance updates

Recent updates

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18
Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02
Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Mar 10
Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Sep 08

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Jun 30

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Apr 12
Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Dec 28
Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

Kewaunee Scientific reports Q2 results

Dec 09

Revenue & Expenses Breakdown
Beta

How Kewaunee Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:KEQU Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Jan 242019320
31 Oct 232157320
31 Jul 232194320
30 Apr 232191300
31 Jan 23215-1300
31 Oct 22195-3280
31 Jul 22180-6260
30 Apr 22169-6260
31 Jan 22158-9260
31 Oct 21151-7260
31 Jul 21151-4270
30 Apr 21147-4260
31 Jan 21143-2250
31 Oct 20144-4270
31 Jul 20145-6260
30 Apr 20148-5260
31 Jan 20148-5270
31 Oct 19146-3250
31 Jul 191441240
30 Apr 191472240
31 Jan 191564230
31 Oct 181625240
31 Jul 181666240
30 Apr 181585230
31 Jan 181485220
31 Oct 171405210
31 Jul 171354200
30 Apr 171395200
31 Jan 171384190
31 Oct 161405190
31 Jul 161354180
30 Apr 161294170
31 Jan 161253170
31 Oct 151203160
31 Jul 151193170
30 Apr 151194170
31 Jan 151164170
31 Oct 141144160
31 Jul 141104160
30 Apr 141114160
31 Jan 141164160
31 Oct 131174170
31 Jul 131224170
30 Apr 131173170

Quality Earnings: KEQU has high quality earnings.

Growing Profit Margin: KEQU became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KEQU's earnings have grown by 19.3% per year over the past 5 years.

Accelerating Growth: KEQU has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: KEQU has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).


Return on Equity

High ROE: KEQU's Return on Equity (19.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.